Ken Griffin Singular Genomics Systems, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.78 - $1.28 $11,154 - $18,304
14,300 Added 3575.0%
14,700 $12,000
Q1 2023

May 15, 2023
BUY
$1.1 - $2.95 $330 - $885
300 Added 300.0%
400 $0
Q4 2022

Feb 14, 2023
BUY
$1.82 - $2.71 $182 - $271
100 New
100 $0

Others Institutions Holding OMIC

# of Institutions
2
Shares Held
1.43M
Call Options Held
0
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $440M
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email